San Francisco-based healthtech firm Kinsa has raised $17m in a funding round led by GSR Ventures, FirstMark Capital and Kleiner Perkins Caufield Byers. Kinsa has developed a suite of smartphone-connected thermometers that are sold online and in stores such as Target and CVS across the US. The company is also working on an app for tracking blood sugar levels to help people manage their diabetes more effectively. Among Kinsa's plans for the future are the development of real-time fever guidance, medication reminders and connections to physicians.
San Francisco-based healthtech firm Kinsa has raised $17m in a funding round led by GSR Ventures, FirstMark Capital and Kleiner Perkins Caufield Byers. Kinsa has developed a suite of smartphone-connected thermometers that are sold online and in stores such as Target and CVS across the US. The latest round brings total funding for the company to $28.6m and the money will be used to develop additional smart services and products. Among Kinsa's plans for the future are the development of real-time fever guidance, medication reminders and connections to physicians.